Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts

Journal of Bone and Mineral Research

Volumn 17, Issue 8, 2002, Pages 1486-1497

  Suzuki, K ^a   Zhu, B ^a   Rittling, S R ^b   Denhardt, D T ^b   Goldberg, H A ^c   Mcculloch, C A G ^a   Sodek, J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

CD44; Cell migration; Osteoclastogenesis; Osteoclasts; Osteopontin

Indexed keywords

BETA1 INTEGRIN; BETA3 INTEGRIN; CYCLOHEXIMIDE; HERMES ANTIGEN; OSTEOPONTIN; SIALOPROTEIN; SIALOGLYCOPROTEIN; SPP1 PROTEIN, MOUSE; SPP1 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL FUSION; CELL MIGRATION; CELL MOTILITY; CELL SPREADING; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FILOPODIUM; IMMUNOFLUORESCENCE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PSEUDOPODIUM; RAT; ANIMAL; C57BL MOUSE; CELL MOTION; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MOUSE; PHYSIOLOGY; WISTAR RAT;

ANIMAL; ANTIGENS, CD44; CELL FUSION; CELL MOVEMENT; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; OSTEOCLASTS; RATS; RATS, WISTAR; SIALOGLYCOPROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; OSTEOPONTIN;

EID: 0035992868     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.8.1486     Document Type: Article

References (55)

1. Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: Demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy
2. Differential screening identifies genetic markers of monocyte to macrophage maturation
3. Coordinate expression of OPN and associated receptors during monocyte/macrophage differentiation of HL-60 cells
4. Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in ratibiae
5. Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone
6. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro
7. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption
8. Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin
9. Osteopontin: A protein with diverse functions
10. Osteopontin
11. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo
12. Osteopontin
13. Osteopontin function in pathology: Lessons from osteopontin-deficient mice
14. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling and cell survival
15. Receptorligand interaction between CD44 and osteopontin (Eta-1)
16. Eta-I (osteopontin): An early component of type-I (cell-mediated) immunity
17. Multiple forms of Sppl (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: Regulation by TGF-beta
18. Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells
19. Regulation of osteopontin expression in osteoblasts
20. The inhibitory activity of osteopontin on hydroxyapatite formation in vitro
21. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro
22. CD44 is the principal cell surface receptor for hyaluronate
23. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition
24. Splicing choice from ten variant exons establishes CD44 variability
25. CD44: Structure, function, and association with the malignant process
26. ERM proteins: Head-to-tail regulation of actin-plasma membrane interaction
27. Direct involvement of ezrin/radixin/moesin (ERM)-binding membrane proteins in the organization of microvilli in collaboration with activated ERM proteins
28. CD44 variants but not CD44s cooperate with beta 1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis
29. Intracellular OPN is an integral component of the CD44-ERM complex involved in cell migration
30. Separation of mouse spleen cells by passage through column of Sephadex G-10
31. Characterization of fetal porcine bone sialoproteins: Secreted phosphoprotein I (SPPI, osteopontin), bone sialoprotein, and a 23 kDa glycoprotein. Demonstration that the 23 kDa glycoprotein is derived from the carboxy-terminus of SPPI
32. Echistatin inhibits the migration of marine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells
33. Integrins and signaling in osteoclast function
34. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation
35. Bone sialoprotein
36. Tumor necrosis factor-alpha (TNFα) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type I receptor and RANK signaling pathways
37. Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin
38. Functional significance of intracellular osteopontin associated with the CD44 receptor complex
39. Immunolocalization of CD44 and the ERM family in bone cells of mouse tibiae
40. Establishment of an osteocyte-like cell line, MLO-Y4
41. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity
42. Osteopontin-deficient mice (OD-) cells exhibit enhanced actin fibre formation and spreading while OD-osteoclasts are less efficient in removing hydroxyapatite coated on glass and in recruitment to ectopically implanted bone matrix
43. Osteopontin-deficient mice reveal increase in osteoclast number, enhanced TRANCE/RANKL/ODF expression in bone but are resistant to bone resorption that follows bone formation after bone marrow ablation
44. Osteopontin: A versatile regulator of inflammation and biomineralization
45. Osteopontin antisense deoxyoligonucleotides inhihit bone resorption by mouse osteoclasts in vitro
46. Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor
47. Role of alpha(v)-beta(3) integrin in osteoclast migration and formation of the sealing zone
48. 3 integrins are osteosclerotic due to dysfunctional osteoclasts
49. CD44 antibodies inhibit osteoclast formation
50. Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC
51. Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts
52. Introduction of antisense CD44S cDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells
53. mRNA expression of MTI-MMP, MMP-9, cathepsin K, and TRAP in highly enriched osteoclasts cultured on several matrix proteins and ivory surfaces
54. Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength
55. Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: A new approach to investigating pathogenesis